EUVIMEDEUVIMED entdecken
Crossref

Polysaccharides from Cistanche deserticola Ma prevent alcoholic fatty liver disease by regulating hepatic lipid metabolism and gut microbiota in mice

Kai Wang, Haichao Wang, Qihui Sun, Xuefang Kou, Pei Yang, Xinyuan Zhai, Yaying Li, Shangshen Yang, Xiaoming Wang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Kai Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Polysaccharides, Fatty Liver, Alcoholic, Cistanche. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Shandong Provincial Postdoctoral Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cistanche deserticola Ma polysaccharide (CDP) is an active ingredient extracted from Cistanche deserticola Ma (CD) and is believed to have hepatoprotective activity. However, the molecular mechanism of its hepatoprotective effect by intervening in alcoholic fatty liver disease (AFLD) remains unclear. In the present study, three polysaccharides were isolated and purified from CD, and the polysaccharide with the better lipid-lowering and liver-protecting activity and the highest yield, CDPS, was selected by in vitro experiments for subsequent. The efficacy of CDPS in ameliorating AFLD in mice was evaluated using hepatic lipidomics, 16S rRNA analysis and molecular biology experiments. The present study showed that CDPS significantly improved alcohol-induced weight loss, lipid accumulation, ALT, AST, inflammation and dyslipidemia, suggesting that CDPS can prevent AFLD. Lipidomics showed that CDPS improved lipid metabolism disorders by regulating glycerophospholipid metabolism, linoleic acid metabolism, and arachidonic acid metabolism. 16S rRNA analysis showed that CDPS ameliorated alcohol-induced gut microbiota disruption. In particular, CDPS supplementation reduced the abundance of Bacteroides, Parabacteroides, and Escherichia-Shigella and increased the abundance of Ruminococcaceae_UCG-010, Lachnospiraceae_NK4A136_group and Faecalibaculum abundance, and promoted the production of SCFAs. We further used Western blotting to determine the levels of proteins involved in lipogenesis and catabolism, and CDPS intervention resulted in decreased levels of lipid synthesis-associated proteins (SREBP-1c and FAS) and increased levels of lipid catabolism-associated proteins (PPARα) and p-AMPK/AMPK ratio. Our results suggest that CDPS has the potential to prevent AFLD by modulating lipid metabolism, altering the gut microbiota, increasing the content of SCFAs, activating the AMPK signaling pathway to promote fatty acid β-oxidation and limiting fatty acid biosynthesis, which provides a basis for further development of therapeutic drugs for AFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomePolysaccharidesFatty Liver, AlcoholicCistancheLiverAnimalsLipid MetabolismMaleMiceMice, Inbred C57BLHumansDisease Models, AnimalRNA, Ribosomal, 16S

Stichwörter der Autor:innen

Alcoholic fatty liver diseaseCistanche deserticola MaGut microbiotaHepatic lipid metabolismPolysaccharides

Substanzen

PolysaccharidesRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
  • School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
  • Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China.
  • Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, China; Shandong Provincial Key Laboratory of Traditional Chinese Medicine for Basic Research, Shandong University of Traditional Ch…

Förderung

  • Shandong Provincial Postdoctoral Science Foundation
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Wang, K., Wang, H., Sun, Q., Kou, X., Yang, P., Zhai, X., Li, Y., Yang, S., & Wang, X. (2025). Polysaccharides from Cistanche deserticola Ma prevent alcoholic fatty liver disease by regulating hepatic lipid metabolism and gut microbiota in mice. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114707

Vancouver

Wang K, Wang H, Sun Q, Kou X, Yang P, Zhai X, et al. Polysaccharides from Cistanche deserticola Ma prevent alcoholic fatty liver disease by regulating hepatic lipid metabolism and gut microbiota in mice. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114707

BibTeX
@article{Wang2025,
  author = {Wang, Kai and Wang, Haichao and Sun, Qihui and Kou, Xuefang and Yang, Pei and Zhai, Xinyuan and Li, Yaying and Yang, Shangshen and Wang, Xiaoming},
  title = {Polysaccharides from Cistanche deserticola Ma prevent alcoholic fatty liver disease by regulating hepatic lipid metabolism and gut microbiota in mice},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114707}
}
Kostenlos starten →